A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

NCT02201511 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 3 mg PF-06412562 MR tablets_Fasted
DRUG: 2 x 15 mg PF-06412562 MR tablets_Fasted
DRUG: 2 x 15 mg PF-06412562 MR tablets_Fed
DRUG: 10 mg PF-06412562 IR tablets

Sponsor

Pfizer